Ketamine Clinical Trials
The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction in Patients 75 Years of Age or Older and Undergoing Cardiac Surgery
To see complete record on clinicaltrials.gov, please visit this link
Id: NCT02554253
Organisation Name: Mayo Clinic
Overal Status: Completed
Start Date: September 2015
Last Update: February 15, 2022
Lead Sponsor: Mayo Clinic
Brief Summary: Ketamine is a commonly used anesthetic medication which is used for induction of anesthesia as well as as an analgesic. It has been shown to have anti-inflammatory properties which may decrease post-operative complications following cardiac surgery with cardiopulmonary bypass that are thought to associated with inflammation. Some studies have shown that ketamine does decrease these complications when compared with anesthetics that are not commonly used in our cardiac anesthesiology practice. Propofol is another commonly used anesthetic medication which is used for induction of anesthesia. Ketamine has not been compared with propofol for potential to reduce post-operative complications associated with the inflammatory process. This study aims to see if ketamine will reduce the incidence of cognitive dysfunction, delirium, and renal dysfunction in comparison with propofol. In addition, the hemodynamic impact of ketamine compared propofol will be investigated.
Conditions:
- Cognitive Disorders
- Delirium
- Acute Kidney Injury
Total execution time in seconds: 0.3838050365448